TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
FDMT

4D Molecular Therapeutics Inc

Healthcare · Biotechnology · —

14.70$ +6.7% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns 4D Molecular Therapeutics Inc (FDMT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.8% of the shares are freely tradable; institutional investors hold 98.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 98.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 3.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 76.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 25.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 55Mio.

Largest Shareholders

Institutions

Institutions FDMT
Name Stake (%) Shares Change (%) Date
HHG PLC 9.50 5,247,151 +13.2 03/31/2026
RA Capital Management, LLC 9.14 5,049,779 -10.7 03/31/2026
The Goldman Sachs Group Inc 7.61 4,205,438 -2.3 03/31/2026
BlackRock Inc 7.50 4,145,303 +2.0 03/31/2026
Novo A/S 6.61 3,650,737 +0.0 03/31/2026
Bvf Inc 5.21 2,879,289 -37.8 03/31/2026
State Street Corp 4.90 2,707,875 +0.7 03/31/2026
Adage Capital Partners Gp LLC 4.07 2,249,203 +40.1 06/30/2026
Trails Edge Capital Partners, LP 4.03 2,227,917 +71.0 06/30/2026
Vanguard Capital Management, LLC 3.97 2,195,578 +0.0 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings FDMT
Person Role Shares Value As of Type
Kirn David See Remarks 767,486 11,282,044 $ Sep 14, 2026 direct
Bizily Scott Chief Legal Officer 8,617 126,670 $ Sep 1, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 14, 2026 Kirn David See Remarks Sell 58,333 13.90 811,004
Sep 1, 2026 Bizily Scott Chief Legal Officer Sell 584 14.00 8,176
Sep 1, 2026 Bizily Scott Chief Legal Officer Other 584 6.49 3,790
Aug 19, 2026 Kirn David See Remarks Sell 25,927 16.42 425,651
Aug 19, 2026 Kirn David See Remarks Sell 43,149 15.36 662,622
Aug 19, 2026 Kirn David See Remarks Other 50,000 4.14 207,000
Aug 17, 2026 Bizily Scott Chief Legal Officer Sell 1,635 12.20 19,947
Aug 17, 2026 Bizily Scott Chief Legal Officer Other 1,635 4.14 6,769
Aug 13, 2026 Bizily Scott Chief Legal Officer Sell 1,635 12.00 19,620
Aug 13, 2026 Bizily Scott Chief Legal Officer Other 1,635 4.14 6,769
Aug 4, 2026 Kirn David See Remarks Sell 26,842 10.23 274,596
Aug 3, 2026 Kirn David See Remarks Sell 12,415 10.05 124,722
Jul 10, 2026 Kirn David See Remarks Sell 442 12.84 5,673
Jul 10, 2026 Kirn David See Remarks Sell 15,283 12.01 183,560
Jul 9, 2026 Kirn David See Remarks Sell 42,608 12.87 548,177

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?